Nucleosides, Nucleotides & Nucleic Acids publishes research articles, short notices, and concise, critical reviews of related topics that focus on the chemistry and biology of nucleosides, nucleotides, and nucleic acids. Complete with experimental details, this all-inclusive journal emphasizes the synthesis, biological activities, new and improved synthetic methods, and significant observations related to new compounds. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
Access the Genetic Engineering & Biotechnology News (GEN)podcast interview with Eugene Kolker, PhD, Seattle Children's Hospital, Seattle Children's Research Institute, and Editor-in-Chief, OMICS and Vural Ozdemir, MD, PhD, University of Montreal here:THE EMERGING FIELD OF NUTRIGENOMICSOMICS: A Journal of Integrative Biology is the only peer-reviewed journal to span all the OMICS-es to date, including: Genomics (the quantitative study of genes, regulatory and non-coding sequences) Transcriptomics (RNA and gene expression) Proteomics (protein expression) Metabolomics (metabolites and metabolic networks)Additionally, the Journal explores advances in the era of post-genomic biology and medicine, including: Pharmacogenomics (the quantitative study of how genetics affects hosts' responses to drugs) Physiomics (physiological dynamics and functions of whole organisms)The Journal covers the integration of many areas of biology and reports on the latest omics research, developments, and discoveries such as: Physical mapping and sequencing Gene and protein expression Peptide identifications Bacterial coding capabilities Developments in plant research Spectral analysis methods.
Oncogene covers all aspects of the structure and function of oncogenes, especially: * Cellular oncogenes and their mechanism of activation * Structure and function of their encoded proteins * Oncogenes of the DNA and RNA tumour viruses * The molecular oncology of human tumours * Tumour suppressor genes * Growth regulatory genes * Cell cycle control * Growth factors and receptors * Apoptosis * Immortalisation and cellular senescence.
PLoS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales—from molecules and cells, to patient populations and ecosystems—through the application of computational methods. Readers include life and computational scientists, who can take the important findings presented here to the next level of discovery.Research articles that primarily describe new methods and offer only limited biological insight will be considered only in those exceptional instances in which the method is expected to significantly impact the field of computational biology, typically making substantial breakthroughs in areas of demonstrated importance. Research articles modeling aspects of biological systems should demonstrate both scientific novelty and profound new biological insights. Research articles describing improved or routine methods, models, software, and databases will not be considered by PLoS Computational Biology, and may be more appropriate for PLoS ONE.Generally, reliability and significance of biological discovery are validated and enriched by experimental studies. Experimental validation is not required for publication, however, nor does experimental validation of a modest biological discovery render a manuscript suitable for PLoS Computational Biology.For all submissions, authors must clearly provide detail, data, and software to ensure readers' ability to reproduce the models, methods, and results.Authors unsure of whether their work is within the scope of the journal should submit a presubmission inquiry.
Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.PLoS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Our emphasis is on studies of broad interest that provide significant mechanistic insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.Please refer to our Author Guidelines and Frequently Asked Questions when you are preparing manuscripts for submission. If you are unsure whether your work is suitable for PLoS Genetics, you can send a Presubmission Inquiry.
Bacteria, fungi, parasites, prions and viruses cause a plethora of diseases that have important medical, agricultural, and economic consequences. Moreover, the study of microbes continues to provide novel insights into such fundamental processes as the molecular basis of cellular and organismal function. PLoS Pathogens reflects the full breadth of research in these areas by publishing outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms. Topics include (but are not limited to) adaptive and innate immune defenses as well as pathogen countermeasures, emerging pathogens, evolution, genomics and gene regulation, model host organisms, pathogen-cell biology, pathogenesis, prions, proteomics and signal transduction, rational vaccine design, structural biology, and virulence factors.PLoS Pathogens will consider studies that provide fundamental new understanding of the pathogen or pathogenic mechanisms. The journal will not consider purely descriptive studies, such as those that solely identify a new genomic sequence of a related pathogen or a series of related pathogens, the isolation of pathogen variants, or a new strain or type based only on sequence analysis. Such studies, as well as correlative studies of host and pathogen genotypes, would be considered if they use further experiments to test an idea or validate a mechanistic model, or to provide a clear set of novel conclusions that derive from the data.
Pharmacogenetics and Genomics is a unique and innovative journal that covers genetic variation in response to drugs and other chemicals in humans and animals. Its impressive impact factor rating of 4.409 (Pharmacology and Pharmacy, Genetics and Heredity, and Biotechnology & Applied Microbiology, 2008 SCI169; Report) is testament to its quality and standing in this field.Pharmacogenetics and Genomics unites contributions of importance to clinical pharmacologists, biochemists, geneticists, epidemiologists and molecular biologists. The journal publishes studies that identify and characterize polymorphic genes encoding drug metabolizing enzymes, drug receptors and drug transporters. Coverage also includes papers on the effects of gene expression on the disposition and metabolism of foreign chemicals.Full text online at www.pharmacogeneticsandgenomics.com.
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Pharmacogenomics aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.
The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.
Physiologia Plantarumis an international journal committed to publishing the best full-length original research papers that advance our understanding of the primary physiological. molecular and genetic mechanisms governing plant development. growth and productivity; including plant interactions with the biotic and abiotic environment. The journal also publishes Minireviews and Technical Focus papers. with the aim of providing a forum for the exchange of information on recent breakthroughs and technical advances. Aims and Scope AIMS AND SCOPE Physiologia Plantarumis an international journal committed to publishing the best full-length original research papers that advance our understanding of the primary physiological. molecular and genetic mechanisms governing plant development. growth and productivity; including plant interactions with the biotic and abiotic environment. The journal also welcomes submission of shorter breakthrough manuscripts containing novel. exciting but solidly underpinned research that merits rapid publication. The journal publishes papers on all aspects of all organizational levels of experimental plant biology ranging from molecular and cell biology. biochemistry and biophysics to ecophysiology and global change biology. Physiologia Plantarumalso publishes Minireviews and Technical Focus papers. with the aim of providing a forum for the exchange of information on recent breakthroughs and technical advances. REGULAR MANUSCRIPTS Regular manuscripts should present original hypothesis-driven research in one of the five subject areas covered by the journal (Biochemistry and Metabolism; Ecophysiology. Stress and Adaptation; Uptake. Transport and Assimilation; Development. Growth and Differentiation; Photobiology and Photosynthesis). The experiments described should address questions pertinent to the research topic and the outcomes should advance our understanding of the processes being studied. not simply repeat known results in a different species. MINIREVIEWS(Download guidelines in PDF format) Minireviews. which are subject to peer review. should cover the background of a topical research problem. emphasizing the state of the art and serving as a focal point for further research. They must be written concisely. with no more than 50 references and a maximum of 6 printed pages (one printed page of full text is equivalent to around 5600 characters. including spaces). Minireviews will be considered in all areas of experimental plant science and it is recommended that the Editor-in-Chief be contacted in advance to confirm the suitability of the chosen topic. TECHNICAL FOCUS The Technical Focus section is a forum for critical evaluations and syntheses of key technological approaches in plant physiology. including evaluations of limitations or pitfalls of techniques. The Editors invite contributions on topics of interest from recognized experts but also invite proposals from authors for Technical Focus manuscripts. The format is flexible to accommodate varying content.
Physiological Genomics publishes the results of a wide variety of experimental and computational studies from human and model systems to link genes and pathways to physiological functions. The journal encourages the submission of research utilizing genomics, epigenomics, proteomics, metabolomics, and other systems approaches together with novel technologies linking genes to the function of complex biological pathways.
Physiological and Molecular Plant Pathology provides an International forum for original research papers, reviews, and commentaries on all aspects of the molecular biology, biochemistry, physiology, ultrastructure, genetics and evolution of plant-microbe interactions.Papers on all kinds of infective pathogen, including viruses, prokaryotes, fungi, and nematodes, as well as mutualistic organisms such as Rhizobium and mycorrhyzal fungi, are acceptable as long as they have a bearing on the interaction between microbe and plant.Research Areas Include:• Applications of mutagenesis and recombinant DNA technology to the elucidation of processes involved in host-parasite interactions• Genetics of pathogenicity• Genetical basis of host recognition• Molecular basis of recognition; receptors and exogenous and endogenous elicitors• Plasmids and infection processes; tumorigenesis• Structure/activity relationships of toxins, sites of action• Growth regulators and metabolic regulation• Molecular biology of enzyme systems involved in infection processes• Cell wall modifications and resistance to infection• Molecular biology of phytoalexins and other secondary metabolites of the host and their roles in resistance• Predisposition and induced susceptibility• Transport of organic and inorganic nutrients in the infected plant; source-sink relationships
PLANT BREEDING publishes full-length original manuscripts and review articles on all aspects of plant improvement, breeding methodologies, and genetics to include qualitative and quantitative inheritance and genomics of major crop species. PLANT BREEDING provides readers with cutting-edge information on use of molecular techniques and genomics as they relate to improving gain from selection. Since its subject matter embraces all aspects of crop improvement, its content is sought after by both industry and academia. Fields of interest: Genetics of cultivated plants as well as research in practical plant breeding.
Plant Gene encourages
Plant Methods is ready to receive manuscripts on all aspects of plant biology examined from a technological viewpoint.
Plant Molecular Biology is an international journal dedicated to rapid publication of original research in all areas of plant biology. Since its founding in 1981, it has continually ranked among the leading journals. Coverage addresses important biological problems of broad interest. Coverage includes research in comparative genomics, functional genomics, proteomics, bioinformatics, computational biology, biochemical and regulatory networks, and biotechnology. Preference is given to publication of results that provide significant new insights into biological problems and that advance the understanding of structure, function, mechanisms, or regulation. The Editor-in-Chief is Wilhelm Gruissem, Institute of Plant Sciences, Swiss Federal Institute of Technology, Zurich.
This international journal, owned and edited by the British Society for Plant Pathology, covers all aspects of plant pathology and reaches subscribers in 80 countries. Top quality original research papers and critical reviews from around the world cover: diseases of temperate and tropical plants caused by fungi, bacteria, viruses, phytoplasmas and nematodes; physiological, biochemical, molecular, ecological, genetic and economic aspects of plant pathology; disease epidemiology and modelling; disease appraisal and crop loss assessment; and plant disease control and disease-related crop management.
Plant Physiology® (ISSN 0032-0889, online 1532-2548) is published monthly, in three volumes per year, by the American Society of Plant Biologists (ASPB), and is produced by Dartmouth Journal Services, Waterbury, VT. The online journal is the journal of record.Established in 1926, Plant Physiology® is an international journal devoted to physiology, biochemistry, cellular and molecular biology, genetics, biophysics, and environmental biology of plants. Plant Physiology® is one of the world's oldest and most well-respected plant science journals.For information about institutional subscriptions, contact Suzanne Cholwek at ASPB Institutional Subscription Services. For information about the prices for individual subscriptions, which are available to members of the American Society of Plant Biologists, contact ASPB Member Services. You may also update your mailing address for subscriptions or membership contact information. .